Page last updated: 2024-08-16

primaquine and myelin oligodendrocyte glycoprotein (35-55)

primaquine has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bombeiro, AL; Bonfanti, AP; da Costa, TA; de Carvalho, AC; de Oliveira, AL; Di Gangi, R; Ferreira, IT; Issayama, LK; Thomé, R; Verinaud, L; Zanucoli, F1

Other Studies

1 other study(ies) available for primaquine and myelin oligodendrocyte glycoprotein (35-55)

ArticleYear
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
    CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:12

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Calcium-Binding Proteins; Central Nervous System; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Forkhead Transcription Factors; Freund's Adjuvant; Glial Fibrillary Acidic Protein; Mice; Mice, Inbred C57BL; Microfilament Proteins; Myelin-Oligodendrocyte Glycoprotein; Nerve Tissue Proteins; Peptide Fragments; Primaquine; Severity of Illness Index; T-Lymphocytes, Regulatory

2014